Cognitive Behavioural Therapy For People Research Articles

Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial

Objectives To evaluate the effectiveness of integrated motivational interviewing and cognitive behavioural therapy in addition to standard care for patients with psychosis and a comorbid substance use problem.Design Two centre,...

Cognitive behaviour therapy for first episode psychosis: Good for nothing or fit for purpose?

The main objective of this paper is to review the literature regarding studies of cognitive behaviour therapy (CBT) for people with first episode psychosis or early psychosis. A comprehensive search of the PsycINFO and MEDLINE databases identified twelve studies, including several randomised controlled trials and quasi‐experimental studies. There were few significant differences between groups at end of treatment or at follow‐up, and no differences in rates of relapse or readmission. The findings suggest, however, that CBT does have important benefits in terms of rate of recovery, improvements in certain symptoms (e.g. auditory hallucinations and hopelessness) and quality of life. Thus, there is modest support for the application of CBT for people experiencing early psychosis; however, the studies to date have difficulties with study design, theoretical underpinnings and how well the treatment targets fit with the CBT model. Future research addressing these issues is required to determine whether CBT for early psychosis may prove to be more effective than current data would suggest.

Cognitive behaviour therapy versus standard care for schizophrenia

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness of adjunct cognitive behavioural therapy for people with schizophrenia compared to standard care alone. To compare the effect the following variables have on outcome: (i) people in their first episode of illness with those who have a longer history of illness (ii) level of therapist experience and qualification (iii) length of treatment/number of sessions.

A study of effectiveness: cognitive behavioral therapy for people living with HIV/AIDS

This study investigated the effects of a Cognitive Behavioral group therapy (Eurovihta Project) applied with people living with HIV/AIDS. The sample was composed by 89 people REVISTA BRASILEIRA DE TERAPIAS COGNITIVAS, 2008, Volume 4, Numero 2 DOI: 10.5935/1808-5687.20080017

Cognitive behavioural therapy for people with learning disabilities: focus on anger

Cognitive behavioural therapy (CBT) is being used increasingly with people with learning disabilities. The evidence base to support these developments comes from uncontrolled trials of CBT in a variety of psychological disorders and eight to nine controlled trials of CBT for anger (plus a single controlled study in depression). This paper reviews the evidence for the effectiveness of group‐based anger management and the acquisition of anger coping skills, and the effectiveness of individual anger treatment, with some discussion of the status of CBT for other indications and the difficulties of conducting outcome research in this area.

CBT for people with learning disabilities

Cognitive behaviour therapy (CBT) has been increasing in popularity as a therapy in recent years. Using a discussion of literature and a case study this paper advocates the use of CBT within learning disability services. The authors suggest that there need to be several developments for CBT to be more widely used in learning disability services. More research is required in the area to develop an evidence base for the use of mental health therapies with people with learning disabilities.

Depression, Social Context and Cognitive Behavioural Therapy for People who have Intellectual Disabilities

Background It is striking that although cognitive behavioural therapy was developed to treat depression in the general population, there remains a paucity of research concerning its application to people with intellectual disabilities. Recent research points to the importance of understanding people's distress in the context of their particular life experience.Areas to be addressed This paper examines how the life experience of people with intellectual disabilities may influence the nature of their self‐perceptions and their vulnerability to depression. In addition to considering the impact of experience on the content of participants’ self‐perceptions, evidence concerning the mediating role played by cognitive factors in the genesis and maintenance of depression is also reviewed.Conclusions These strands of research are discussed in the light of existing CBT models of depression, along with potential adaptations of interventions for people with intellectual disabilities.

Cognitive Behaviour Therapy for People with Asperger Syndrome

People with Asperger syndrome (AS) appear to have higher than expected rates of co-morbid psychiatric disorder. The main co-morbid diagnoses are anxiety disorders and depression, but eating disorders, obsessive compulsive disorder, substance abuse and bipolar affective disorder have all been reported. Cognitive Behaviour Therapy (CBT) is used effectively to treat these conditions, so could it be used in people who also have Asperger syndrome? This paper reviews important components and characteristics of cognitive behaviour therapy in relation to its use with people who have Asperger syndrome with reference to the relevant literature and to feedback from people with AS. The use of CBT in people with Asperger syndrome appears promising, but further work is needed to evaluate its effectiveness and to examine which particular aspects of therapy are helpful.

Cognitive Behaviour Therapy for People with Cancer

Cognitive Behaviour Therapy for People with Cancer

Cognitive Behaviour Therapy for People with Cancer S. Moorey & S. Greer Oxford: Oxford University Press, 2002, £24.95 pb, 208 pp., ISBN: 0-19-850866-2

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Book Review: Cognitive behaviour therapy for people with cancer

Book Review: Cognitive behaviour therapy for people with cancer

Cognitive behaviour therapy for people with cancer

Cognitive behaviour therapy for people with cancer

Cognitive behaviour therapy for schizophrenia.

Medication is the mainstay of treatment for schizophrenia. Many people with schizophrenia, however, continue to experience symptoms in spite of medication and may experience side effects that are unwanted and unpleasant. In addition to medication additional forms of treatment include talking therapies such as cognitive behavioural therapy. This approach helps to link the person's feelings and patterns of thinking which underpin distress. To review the effectiveness of cognitive behavioural therapy for people with schizophrenia, when compared to standard care, specific medication, other therapies and non-intervention. Electronic searches of Biological Abstracts (1980-1998), CINAHL (1982-1998), The Cochrane Library (Issue 2, 1998), The Cochrane Schizophrenia Groups' Register of Trials, which encompasses up to date searches of all listed databases (January 2001), EMBASE (1980-1998), MEDLINE (1966-1998), PsychLIT (1887-1997), SIGLE (1990-1998), Sociofile (1980-1998) were undertaken. All references of the articles selected were searched for further relevant trials. This review includes relevant randomised trials of cognitive behaviour therapy for people with a diagnosis of schizophrenia-like illnesses. Outcomes such as death, mental state, relapse, psychological well-being and acceptability of treatment were sought. Studies were reliably selected and assessed for methodological quality. Data were extracted by two reviewers working independently. Dichotomous data were analysed on an intention-to-treat basis and continuous data with 65% completion rate are presented. Where possible, for dichotomous outcomes, a relative risk (RR) with the 95% confidence interval (CI) was estimated along with the number needed to treat statistic (NNT). Twenty-two relevant papers describing thirteen trials were identified. Cognitive behavioural therapy in addition to standard care did not significantly reduce the rate of relapse and readmission to hospital when compared with standard care alone (medium term 1 RCT, N=61, RR 0.1 CI 0.01 to 1.7; long term 2 RCTs, N=123, RR 1.1 CI 0.8 to 1.5). A significant difference was observed, however, favouring cognitive behavioural therapy over standard care alone, in terms of being able to be discharged from hospital (1 RCT, N=62, RR 0.5 CI 0.3 to 0.9, NNT 3 CI 2 to 12). For 'no important improvement in mental state' data showed a significant difference favouring the cognitive behavioural therapy group over standard care alone when measured at 13 to 26 weeks (2 RCTs, N=123, RR 0.7 CI 0.6 to 0.9, NNT 4 CI 2 to 8). After one year the difference was no longer significant (3 RCTs, N=211, RR 0.95 CI 0.6 to 1.5). On continuous measures (BPRS, CPRS, Psychiatric Assessment Scale) data are not convincing of an effect. A cognitive behavioural therapy approach focusing on compliance may have some effects on insight and attitudes to medication, but the clinical meaning of these data is unclear. When compared with supportive psychotherapy, cognitive behavioural therapy had no effects on relapse rate and clinically meaningful improvements in mental state. Cognitive behavioural therapy combined with other psycho-social/educational interventions may decrease the numbers of people able to tolerate the intervention, at least under study conditions. Cognitive behavioural therapy is a promising but under evaluated intervention. Currently, trial-based data supporting the wide use of cognitive behavioural therapy for people with schizophrenia or other psychotic illnesses are far from conclusive. More trials are justified, especially in comparison with a lower grade supportive approach. These trials should be designed to be both clinically meaningful and widely applicable.

Book Review: Cognitive-Behaviour Therapy for People With Learning Disabilities

Book Review: Cognitive-Behaviour Therapy for People With Learning Disabilities

Cognitive Behaviour Therapy for People with Learning Disabilities

Cognitive Behaviour Therapy for People with Learning Disabilities